Yubo International Biotech Ltd (YBGJ)
Yubo International Biotech Ltd (YBGJ)
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -295,026 | 2,090,227 | -902,288 | NaN |
| Depreciation and amortization | 29,071 | 44,419 | 43,588 | 89,766 |
| Loss on obsolete inventory | NaN | NaN | 0 | 0 |
| Loss on obsolescence inventory | NaN | 0 | NaN | NaN |
| Bad debt of prepaid expenses | -29,050 | NaN | NaN | NaN |
| Receivables | -3,824 | -77,638 | 3,718 | 46,979 |
| Prepaid expense | 26,964 | 18,534 | 39,794 | -45,430 |
| Inventory | 0 | -12,919 | 697 | -697 |
| Net loss | NaN | NaN | NaN | -541,059 |
| Due from related parties | 0 | 0 | 5,235 | -5,235 |
| Lease security deposit | 0 | 21,468 | -296 | 80,018 |
| Accounts payable and accrued expenses | 52,889 | 103,532 | -93,298 | 12,662 |
| Advances from prospective customers/distributors | 0 | 5,579 | 2,735 | 8,002 |
| Cash receipts from related parties | NaN | NaN | 0 | NaN |
| Net cash used in operating activities | -207,157 | -128,752 | -359,056 | -354,994 |
| Proceeds for sale of equipment | NaN | -79,904 | 0 | 79,904 |
| Purchases of equipment | 0 | NaN | NaN | NaN |
| Net cash provided in investing activities | 0 | -79,904 | 0 | 79,904 |
| Advances from related parties (net) | 214,523 | 375,626 | 0 | 473,919 |
| Capital contributions to subsidiary | NaN | 0 | 0 | 0 |
| Net cash provided by financing activities | 214,523 | 375,626 | 0 | 473,919 |
| Effect of exchange rate changes | -5,046 | -169,834 | 359,566 | -195,428 |
| Net increase (decrease) in cash | 2,320 | -2,864 | 510 | 3,401 |
| Cash at beginning of period | 8,062 | 10,926 | 7,015 | NaN |
| Cash at end of period | 10,382 | 8,062 | 10,926 | NaN |